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Schizophrenia is a highly heritable disorder with diverse mental and somatic symptoms.
The molecular mechanisms leading from genes to disease pathology in schizophrenia
remain largely unknown. Genome-wide association studies (GWASs) have shown
that common single-nucleotide polymorphisms associated with specific diseases are
enriched in the recognition sequences of transcription factors that regulate physiological
processes relevant to the disease. We have used a “bottom-up” approach and tracked a
developmental trajectory from embryology to physiological processes and behavior and
recognized that the transcription factor NK2 homeobox 1 (NKX2-1) possesses properties
of particular interest for schizophrenia. NKX2-1 is selectively expressed from prenatal
development to adulthood in the brain, thyroid gland, parathyroid gland, lungs, skin, and
enteric ganglia, and has key functions at the interface of the brain, the endocrine-, and the
immune system. In the developing brain, NKX2-1-expressing progenitor cells differentiate
into distinct subclasses of forebrain GABAergic and cholinergic neurons, astrocytes, and
oligodendrocytes. The transcription factor is highly expressed in mature limbic circuits
related to context-dependent goal-directed patterns of behavior, social interaction and
reproduction, fear responses, responses to light, and other homeostatic processes. It is
essential for development and mature function of the thyroid gland and the respiratory
system, and is involved in calciummetabolism and immune responses. NKX2-1 interacts
with a number of genes identified as susceptibility genes for schizophrenia. We suggest
that NKX2-1 may lie at the core of several dose dependent pathways that are
dysregulated in schizophrenia. We correlate the symptoms seen in schizophrenia with the
temporal and spatial activities of NKX2-1 in order to highlight promising future research
areas.
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INTRODUCTION
Schizophrenia is a complex disorder that affects approximately
1% of the world’s population over the age of 18. Although its
heritability is estimated to be as high as 0.7–0.9 (Mulle, 2012),
environmental and/or stochastic influences can still influence the
pathogenesis of this disorder. The two-hit hypothesis, which has
gained considerable support, suggests that an underlying genetic
susceptibility, combined with a distinct developmental insult, i.e.,
an infectious or inflammatory episode, can prime an individual
for a later event that ultimately leads to the onset of the full
clinical syndrome (Bayer and Altman, 2009; Feigenson et al.,
2014).
One of the fundamental goals in understanding schizophrenia
is to link the observable symptoms to the underlying
unobservable pathophysiology. The hallmark symptom is
psychosis, with positive, negative, and cognitive manifestations
(Andreasen et al., 1990). However, the majority of patients
with schizophrenia receive neuroleptic treatment at an early
stage of their illness. Accordingly, the fully evolved phenotype,
as seen in untreated patients prior to the neuroleptic era, is
seldom witnessed today. While being a welcome development
for the patient, this can hamper our understanding of the key
pathophysiological processes involved in schizophrenia. In this
respect, a review of the remarkably detailed phenomenological
studies of schizophrenic patients, conducted prior to the
introduction of neuroleptics, is of particular value.
The most detailed observations of the evolving
symptomatology in schizophrenia were made almost 100
years ago (Kraepelin, 1919). Kraepelin observed a number of
non-psychiatric symptoms in his patients, indicating that several
organ systems and physiological processes were affected.
Neurologic symptoms with spasmodic phenomena,
reminiscent of choreic patients, were one of the observed
dysfunctions. Later studies confirmed that children at high
risk of developing schizophrenia often display neurological
symptoms, including choreatic movements (Walker et al., 1994;
McNeil et al., 2003). The presence and characteristics of these
involuntary movements for patients with untreated psychosis,
which disappear on treatment, indicate that these symptoms
are an intrinsic feature of the disease process. Further, these
involuntary movements imply a fundamental dysfunction in the
cortical-basal ganglia-cortical circuitry (Whitty et al., 2009).
Frequent thyroid dysfunction, including an enlarged gland,
rapid changes in size during progression of the illness, occasional
exophthalmia, tremor, and myxoedema, have also been described
(Kraepelin, 1919). A high incidence of thyroid pathology has
been a consistent feature in reports of schizophrenia, with
the available evidence supporting a role for thyroid hormone
deregulation in the illness. The implication of thyroid hormone
homeostasis in the fine-tuning of crucial brain networks would
appear to warrant further research (Santos et al., 2012; Jose et al.,
2015; Labad et al., 2016).
Furthermore, patients with schizophrenia present with
somewhat accelerated and an excessively deep respiration,
with several anomalies, especially for expiration (Kraepelin,
1919). Subsequently, it has been confirmed that patients
with schizophrenia have an increased risk of lung disease,
with a smoking-independent increase in lung disease-
related mortality (Carney et al., 2006; Copeland et al.,
2007).
Other symptoms and physiologic abnormalities initially
described by Kraepelin, and subsequently confirmed by
others, includes the following; impaired immunity (Anders
and Kinney, 2015; Müller et al., 2015), enteric dysfunction
(Peupelmann et al., 2009), altered calcium homeostasis
(Bojarski et al., 2010), metabolic irregularities (Mitchell
et al., 2013), skin abnormalities (Kamolz et al., 2003; Smesny
et al., 2007); altered sleep patterns (Bromundt et al., 2011),
an abnormal pupillary light reflex (Bar et al., 2008), altered
thermoregulation (Chong and Castle, 2004), and menstrual
patterns (Malik et al., 2011). Taken together, these observations
indicate that, in addition to being a neurodevelopmental
disorder, schizophrenia affects multiple physiologic processes
that may lead to thyroid-, parathyroid- gastrointestinal and
immune system dysfunction, respiratory symptoms, and skin
abnormalities.
Although genetic findings consistently point to a role for genes
involved in transcription/gene expression, neural development,
neurotransmission, and immune function in schizophrenia, the
vast majority of heritability still remains unexplained. However,
an interesting insight has come from analyses of genome-wide
association studies (GWASs) for complex disorders. Common
single-nucleotide polymorphisms appear to be systematically
enriched in transcription factor binding sites, particularly
those active during fetal development (Maurano et al., 2012).
Interestingly, the transcription factors whose activities may be
altered, govern those physiologic processes relevant to the disease
or trait under study.
In aiming to link the observable symptoms to the underlying
unobservable pathophysiology of schizophrenia, we believe
that a “bottom-up” approach where we track a developmental
trajectory from embryology, to physiologic process and
behavior, may be of value. In this fashion, we have come to
recognize that the highly conserved transcription factor NK2
homeobox 1 (NKX2-1, encoded by NKX2-1; GENE ID 7080;
chromosome 14q13), also called thyroid transcription factor
1, or thyroid-specific enhancer binding protein, possesses
properties of particular interest for schizophrenia. Contrary
to many transcription factors that are ubiquitously expressed,
NKX2-1’s expression is restricted to specific parts of the
brain, the thyroid- and parathyroid glands, the skin, lungs,
and enteric ganglia (Bingle, 1997; Suzuki et al., 1998a;
Garcia-Barcelo et al., 2005; Boggaram, 2009; Germain et al.,
2013; Fernandez et al., 2015). NKX2-1 governs multiple
physiologic processes relevant to those somatic symptoms
commonly seen in schizophrenia (as described). NKX2-1
also plays a central role in neurodevelopment and is essential
for the formation and function of subgroups of neurons,
glia, and functional neural networks that are affected in
schizophrenia. This transcription factor also interacts with
several susceptibility genes for schizophrenia, and is involved
in gene-environment interactions with neurodevelopmental
implications.
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Further indications of the possible role of NKX2-1 in the
pathophysiology of schizophrenia came from studies of families
affected by inactivating mutations in NKX2-1. These result
in a syndrome called brain-lung-thyroid disease, or benign
hereditary chorea, which presents with impaired coordination,
delayed speech development, neonatal pulmonary distress, and
congenital hypothyroidism (OMIM#118700) (Krude et al., 2002;
Glik et al., 2008; Yamada et al., 2009; Vloet et al., 2010; Monti
et al., 2015; Peall and Kurian, 2015). Schizophrenia, psychosis,
and behavioral disturbances, have all been reported in several
of the reported pedigrees, suggesting that the association is not
merely coincidental.
The scientific literature gives no indication that a large
proportion of people with schizophrenia could carry a mutation
or copy number variation in the NKX2-1 gene. However, the
influence of a transcription factor on disease processes may not
necessarily be directly linked to a mutation in the transcription
factor itself. Dysregulated pathway activity, as a result of genetic
or epigenetic alterations in downstream target genes, upstream
regulators, transcriptional co-activators, or suppressors, may lead
to genetic and phenotypic heterogeneity that ultimatelymanifests
as a disorder. Accordingly, NKX2-1 may lie at the core of several
dose dependent pathways that are dysregulated in schizophrenia.
To further explore the possible role of NKX2-1 in schizophrenia,
we correlated the symptoms seen in schizophrenia with the
temporal and spatial activities of NKX2-1, in order to highlight
promising future research areas.
NEURODEVELOPMENT AND BRAIN
FUNCTION
The neurodevelopmental hypothesis of schizophrenia proposes
that pathological neurodevelopmental processes begin as early
as the first and second trimester, and result in neuronal
circuits that are primed to generate psychotic symptoms during
adolescence or in young adults. In line with this, Nkx2-1
expression in the mouse brain commences at embryonic day
9 (comparable to the third gestational week in humans), when
Nkx2-1 becomes detectable in a longitudinal band in the ventral
forebrain that encompasses the medial ganglionic eminence
(MGE), the preoptic area, and the ventral hypothalamus (Rakic
and Zecevic, 2003a; Xu et al., 2008; Pauly et al., 2013)
(Figure 1). Nkx2-1 participates in key early developmental events
such as brain parcellation and cellular-fate specification in the
embryonic forebrain (Sussel et al., 1999; Marin et al., 2000;
Flames et al., 2007; Garcia-Lopez et al., 2008). Fate-mapping
studies have shown that the progeny of Nkx2-1 expressing
progenitor cells give rise to subclasses of neurons, astrocytes, and
oligodendrocytes (Marshall and Goldman, 2002; Chojnacki and
Weiss, 2004; Xu et al., 2008) while neurons derived from Nkx2-
1-expressing progenitors are incorporated into specific neural
circuits and networks, astrocytes and oligodendrocytes appear
to be more widely distributed, and are found throughout the
forebrain by the time of birth (Marshall and Goldman, 2002;
Chojnacki and Weiss, 2004; Torigoe et al., 2015). Ultimately, in
mice, the majority of Nkx2-1-expressing oligodendrocytes will be
replaced by other populations of oligodendrocytes in the adult
brain (Kessaris et al., 2006).
Cortical Gabaergic Inhibition
Deficits in cortical GABA neurotransmission are among the most
consistent findings in schizophrenia research (Inan et al., 2013).
It has been suggested that this deficit results from dysfunctional
GABAergic interneurons that share a common developmental
origin, and possibly the same aberrant precursor pool (Fung
et al., 2010). We would suggest that this population represents
the progeny of NKX2-1-expressing progenitors, derived from
the MGE, that then develop into specific subgroups of cortical
GABAergic interneurons.
The GABAergic fate of Nkx2-1 expressing progenitor cells
is determined by downstream activation of the transcription
factor Lim homeobox 6 (Lhx6) (Du et al., 2008; Flandin
et al., 2011). The continuous expression of Lhx6 in post-
mitotic cortical interneurons allows us to trace their ancestry,
even if Nkx2-1 expression is down regulated. Interestingly, a
deficit in cortical LHX6 mRNA expression has been reported
in schizophrenic patients (Volk et al., 2012, 2014). In line
with our suggestions, the authors propose that their finding
implies a dysfunction in a GABAergic interneuron pool in
schizophrenia.
Depending on temporal and spatial factors, Nkx2-1 derived,
Lhx6 expressing GABAergic neuronal progenitors in the MGE
may develop into subclasses of cortical GABAergic interneurons
containing reelin, parvalbumin (PV+), somatostatin (SST+),
calbindin (CB+), neuropeptide Y (NPY+), and nitric oxide
synthase (NOS+) (Chojnacki and Weiss, 2004; Xu et al., 2004;
Fogarty et al., 2007; Butt et al., 2008).
In rodents, early Nkx2-1-expressing progenitors in the MGE
develop into a subpopulation of GABAergic reelin-containing
Cajal-Retzius cells that will populate the (future) cortical layer
I (Lavdas et al., 1999). Whether these will ultimately become
reelin secreting cells is, as yet, unknown. Indirect evidence
for dysfunctional reelin-containing cells in schizophrenia comes
from studies of reeler mice, which are haploinsufficient for reelin,
and share several biochemical and behavioral similarities with
schizophrenic patients (Nullmeier et al., 2011). Among other
abnormalities, reeler mice display impaired cortical lamination
(Dekimoto et al., 2010). In line with this observation, patients
with schizophrenia harbor an aberrant distribution of Cajal-
Retzius cells and display a reduced expression of reelin in cortical
layer I (Kalus et al., 1997; Ruzicka et al., 2007).
Some of the Nkx2-1 derived, reelin-secreting interneurons,
also accumulate as interstitial cells in the medial regions of the
subcortical white matter, at the midline in the corpus callosum,
and in the hippocampus (DeDiego et al., 1994; Lavdas et al.,
1999). In patients with schizophrenia, an aberrant distribution
of interstitial cells and reduced reelin mRNA levels have been
detected in the prefrontal cortex and in the hippocampal
formation (Akbarian et al., 1996; Kirkpatrick et al., 2003;
Eastwood and Harrison, 2006).
Although these findings may suggest that NKX2-1-derived
Cajal-Retzius and interstitial cells are dysfunctional in patients
with schizophrenia, it is important to bear in mind that these
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FIGURE 1 | Early brain development and Nkx2-1 expression in the early embryonic brain. (A) Brain vesicles and divisions in the mammalian brain
corresponding to gestational day 33 in humans. (B) Nkx2-1 is expressed as a longitudinal band in the ventral secondary prosencephalon from the rostral pallidum to
the caudal hypothalamic area (rodent brain E15, corresponding to gestational day 49 in humans). (C) Future basal ganglia develop from subcortical parts of the
telencephalon (“subpallium”). The striatum develops from the lateral ganglionic eminence, and pallidum from the medial ganglionic eminence. (D) Side view illustrating
the medial, lateral, and caudal ganglionic eminences.
cell populations are heterogeneous, and have diverse molecular
origins (Rakic and Zecevic, 2003b).
In mice, Nkx2-1-expressing precursors in the ventral MGE
develop into PV+ interneurons that populate the cerebral cortex
and the striatum. In the cerebral cortex, PV+ interneurons occur
as basket and chandelier cells (Chojnacki and Weiss, 2004; Xu
et al., 2004); approximately 90 and 68% of PV+ interneurons
in the deep and superficial cortical layers, respectively, were
co-labeled with reporter genes for Nkx2-1 (Xu et al., 2008).
Human and animal studies suggest that compromised cortical
PV+ interneuron function is a major hallmark of schizophrenia
(Reynolds et al., 2004; Behrens and Sejnowski, 2009; Curley
et al., 2011; Nullmeier et al., 2011; Nakazawa et al., 2012; Volk
et al., 2012; Jiang et al., 2013; Glausier et al., 2014; Yanagi et al.,
2014; Brisch et al., 2015; Fujihara et al., 2015; Gonzalez-Burgos
et al., 2015). Althoughmost studies report functional impairment
in cortical PV+ interneurons, some studies have also detected
structural alterations (Konradi et al., 2011; Wang A. Y. et al.,
2011).
Inmice, most cortical SST+ interneurons develop fromNkx2-
1-expressing progenitors in the MGE (Xu et al., 2004; Fogarty
et al., 2007; Tricoire et al., 2011; Cai et al., 2013). In the
neocortex, SST+ interneurons occur mainly as small basket cells
in layers IV and V, and Martinotti cells in layers II-III and V-
VI (Viollet et al., 2008). SST+ interneurons constitute 30–50%
of all interneurons in the hippocampus, including bistratified,
axo-axonic, and oriens-lacunosum-moleculare cells (Lawrence,
2008).
The cortical SST+ interneurons have been investigated less
extensively than PV+ interneurons, but evidence is accumulating
to show that their functions are also compromised in patients
with schizophrenia (Hashimoto et al., 2008; Lewis et al., 2008;
Morris et al., 2008; Fung et al., 2010; Beneyto et al., 2012).
For example, the number of SST+ interneurons, as well as
levels of SST mRNA, are both reduced in the hippocampus of
schizophrenic patients (Konradi et al., 2011).
In mice, Nkx2-1-expressing progenitors in the preoptic area
give rise to cortical CB+ interneurons (Fogarty et al., 2007).
In the neocortex, most of this interneuron class occurs in the
upper layers, often at the boundary between layers I and II
(Gelman et al., 2009). Several studies have reported a reduction
in the density of CB+ interneurons in the upper cortical levels
in patients with schizophrenia (Beasley et al., 2002; Cotter
et al., 2002; Reynolds et al., 2004; Chance et al., 2005; Sakai
et al., 2008). Contradicting this, a 40% increase in the density
of CB+ interneurons expressing the NR2A subunit of the N-
methyl-D-aspartate receptor was reported for layer II of the
anterior cingulate cortex in schizophrenic patients (Woo et al.,
2008).
In rodents, cortical calretinin-containing interneurons do
not develop from Nkx2-1-expressing progenitors. In humans,
the NKX2-1 derived cortical calretinin-containing interneurons
would appear to be a relatively minor subpopulation (Yu and
Zecevic, 2011). Thus, far, the majority of studies have failed to
identify any abnormality in calretinin-containing interneurons
in schizophrenia (Beasley et al., 2002; Tooney and Chahl,
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2004). However, decreased expression of calretinin mRNA in the
dorsolateral prefrontal cortex of schizophrenia patients has been
detected in a single study (Fung et al., 2010).
Integration of Information in Cortical-Basal
Ganglia-Thalamocortical Neural Circuits
The basal ganglia receive afferent inputs from different areas
of the cortex and send projections back to the cortex via
the thalamus. This neuronal loop serves as the basis for
various functions, including motor functions, cognitive control,
motivational, and emotional processing. Early observations of
involuntary movements in schizophrenic patients led researchers
to suggest that the cortical-basal ganglia-thalamocortical circuits
might be, in some way, dysfunctional (Whitty et al., 2009). It
is now widely acknowledged that this dysfunction is actually
widespread and contributes substantially to the pathophysiology
of schizophrenia (Siegel et al., 1993; Ellison-Wright et al., 2008;
Yoon et al., 2013; Cordon et al., 2015; Duan et al., 2015).
The progeny of Nkx2-1 expressing progenitors are widely
distributed in cortical-basal ganglia-thalamocortical circuits.
During early development, Nkx2-1 is expressed in both the
dorsal and ventral parts of the striatum and pallidum. However,
persistent expression into adulthood, is most prominent in the
dorsal striatum and globus pallidus (Marin et al., 2000; Nobrega-
Pereira et al., 2010).
The majority of GABAergic and cholinergic interneurons
in the dorsal striatum in rodents are derived from the Nkx2-
expressing progenitors in the MGE and preoptic area (Marin
et al., 2000; Fragkouli et al., 2009; Magno et al., 2011). GABAergic
interneurons belong to different subclasses containing PV, SST,
nitric oxide synthase, neuropeptide Y, or calretinin (Marin et al.,
2000), and modulate the output of neurons in the striatum (the
medium spiny neurons) in a complex and highly orchestrated
manner.
In humans, a major proportion of the NKX2-1 expressing
striatal GABAergic interneurons contain PV (Magno et al.,
2011). These constitute the major component of a powerful
feed-forward inhibition that focuses cortical excitation, and
synchronizes the activity of medium spiny neurons in order
to regulate striatal output (Tepper et al., 2008). Although we
have limited knowledge about the role of striatal GABAergic
interneurons in schizophrenia, striatal PV+ interneurons have
been suggested to play an important role in the behavioral
effects mediated by antipsychotic drugs (Wiltschko et al., 2010).
Indirect indicators of the influence of striatal PV+ interneurons
in schizophrenia have also come from studies of reeler mice
(Marrone et al., 2006; Ammassari-Teule et al., 2009). These
reported a reduced number of striatal PV+ interneurons in all
striatal sub regions, together with behavioral deficits such as fear
extinction and latent inhibition.
In mice, at least 80% of striatal cholinergic interneurons
develop from Nkx2-1-expressing progenitors (Fragkouli et al.,
2009; Magno et al., 2009). Similarly, in the human brain, striatal
cholinergic neurons are NKX2-1-immunoreactive (Magno et al.,
2011). Although little is known about this interneuron group
in schizophrenia, Holt et al. (1999, 2005) found that the mean
density of cholinergic interneurons in the ventral striatum was
reduced to just over a quarter (26%) of that seen in controls.
The globus pallidus is a rather homogenous structure
composed of a network of inhibitory GABA-containing
projection neurons that comprise the final pathway of the
cortical output apparatus. In mice, approximately 75%
of neurons in the globus pallidus develop from Nkx2-1-
expressing progenitors that maintain their expression of
Nkx2-1 into adulthood (Flandin et al., 2010; Nobrega-
Pereira et al., 2010; Abdi et al., 2015; Dodson et al., 2015).
These neurons are PV+ and display a spontaneous high-
frequency discharge. The Nkx2-1 expressing neurons project
through the direct and indirect pathway to the thalamus
and the subthalamic nucleus. Their dendrites often cross
functional borders within the pallidum to receive and
integrate inputs from all parts of the pallidal complex
(Bolam et al., 2000). In contrast, neurons that do not express
Nkx2-1 send their projections back to striatum (Abdi et al.,
2015).
To our knowledge, the projection neurons of the globus
pallidus have not been directly studied in patients with
schizophrenia. However, studies in an animal model based on
the immunoinflammatory hypothesis of schizophrenia suggest
that the globus pallidus may play crucial roles in the behavioral
deficits seen in schizophrenia (Sotoyama et al., 2011). These
include abnormal sensorimotor gating, latent inhibition, social
interaction, working memory, and behavioral sensitization to
dopamine and methamphetamine. In particular, the globus
pallidus neurons in the lateral area display an increased
firing rate that was ameliorated by treatment with risperidone
(Sotoyama et al., 2013). Morphological and functional alterations
of the globus pallidus have also been observed in patients
with schizophrenia. Volumetric analyses, diffusion tensor
imaging, and positron emission tomography, have revealed
microstructural and functional alterations (Velakoulis et al.,
2002; Galeno et al., 2004; Spaniel et al., 2005; Spinks et al., 2005;
Hashimoto et al., 2009). There is also a strong positive correlation
betweenmarkers of inflammatory and endothelial activation, and
the volume of the globus pallidus in patients with schizophrenia
(Dieset et al., 2015).
A Putative Special Role for PV+ Neurons in Data
Integration
The classic view of the organization of the basal ganglia is
that functionally diverse information from the cerebral cortex is
processed in the striatum and subsequent divisions of the basal
ganglia by parallel and segregated circuits; these are organized
in a dorsolateral to ventromedial gradient, from motor to limbic
functions (Alexander et al., 1986) (Figure 2). However, context-
dependent goal-directed patterns of behavior are increasingly
recognized to be dependent on the temporal integration of
limbic, associative, and motor information, rather than relying
on spatial segregation (Bolam et al., 2000; Tisch et al., 2004).
We would suggest that the morphological organization and
functional role of Nkx2-1-derived PV+ neurons in the rodent
cortex, striatum, and pallidum, indicates that these neurons play
a special role in data integration. Cortical PV+ interneurons
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FIGURE 2 | Schematic illustration of information flow through the
direct pathway in cortical-basal ganglia-thalamocortical circuits.
Information from the motor cortex passes to the dorsal striatum, globus
pallidus, ventral lateral thalamus, and back to the motor cortex (red line).
Information from the anterior cingulate and the prefrontal cortex passes to the
ventral striatum, ventral pallidum, mediodorsal thalamus, and back to the
anterior cingulate and prefrontal cortex (blue line).
receive their primary inputs from thalamocortical afferents,
and integrate signals that converge at various parts of the
cortical apparatus via their interneuron network. They mediate
widespread perisomatic feed-forward inhibition to principal
cortical neurons, and participate in the control of their output
to the striatum (Mallet et al., 2005). Striatal PV+ interneurons
receive convergent inputs from functionally different cortical
territories and transmit integrated cortical information to the
principal striatal medium spiny neurons (Ramanathan et al.,
2002; Gage et al., 2010). PV+ projection neurons in the globus
pallidus receive convergent inputs from all regions of the pallidal
complex and integrate motor, associative, and limbic information
(Bolam et al., 2000). The sum of their firing rate (which
fluctuates) modulates the output of the basal ganglia (Elias et al.,
2008) and thalamic activity. The thalamus completes the circuit
by sending robust projections back to cortical PV+ interneurons
and principal cells.
Rodent Nkx2-1 expression is developmentally regulated;
correct spatial and temporal expression is required for the
development and mature function of cortical-basal ganglia-
thalamocortical circuits. Impaired Nkx2-1 expression in murine
basal ganglia leads to substantial changes in coordinated
movement (Magno et al., 2011). For normal mature function,
rodent PV+ interneurons must down-regulate their expression
of Nkx2-1 in the cortex, while achieving a mix of down-
regulation and sustained expression in the allocortex. Conversely,
continual expression of Nkx2-1 is required for the normal
function of striatal PV+ interneurons and pallidal PV+
projection neurons in the basal ganglia (Xu et al., 2008; Magno
et al., 2009).
Accordingly, any aberration in the developmental
regulation of Nkx2-1 expression in PV+ neurons would
alter information processing and integration in cortical-basal
ganglia-thalamocortical circuits, with potentially far-reaching
consequences for context-dependent goal-directed patterns
of behavior. Such behavioral disturbances in patients with
schizophrenia are well-known, having first been described in the
pre-neuroleptic area (Kraepelin, 1919).
Neural Oscillations and Neurogenesis
The functions most affected in schizophrenia require the large-
scale integration of subsystems that use neural oscillations;
these are thought to require a synchronization that enables
flexible communication both within, and between, cortical
areas. Impaired synchrony has emerged as a potentially
fundamental pathophysiological mechanism in schizophrenia.
Aberrant neural oscillations and their synchronization may
account for enduring deficits in cognition, and some of the
psychotic symptoms of the disorder (Uhlhaas and Singer, 2011).
This idea is supported by accumulating evidence of abnormal
theta and gamma activity in patients with schizophrenia
(Schmiedt et al., 2005; Basar-Eroglu et al., 2008; Haenschel et al.,
2009; Hamm et al., 2011; Gonzalez-Burgos et al., 2015).
Nkx2-1 expressing GABAergic and cholinergic neuronal
clusters in the septal area, the diagonal band of Broca, the
ventral pallidum, and the preoptic area play key roles in the
generation of oscillatory activity (Morris and Henderson, 2000;
Siapas et al., 2005; Hangya et al., 2009; Magno et al., 2009, 2011;
Brockmann et al., 2011; McDonald et al., 2011; Griguoli and
Cherubini, 2012). These clusters demonstrate topographically
organized connections to various areas of the brain in order
to influence arousal, sensory processing, emotion, motivation,
learning, memory, andmotor functions (Semba, 2000; Zaborszky
et al., 2008).
The NKX2-1 expressing GABAergic basal forebrain neurons
in humans and rodents have been identified as fast-spiking PV+
projection neurons (Freund, 1989; Magno et al., 2009). They
exhibit burst firing at theta frequency and serve as pacemakers
for the generation of cortical low-frequency theta oscillations
(6–10Hz; Morris and Henderson, 2000; Hangya et al., 2009;
McDonald et al., 2011). In rats, hippocampal theta-burst activity,
originating in the medial septum and ventral diagonal band,
is known to drive oscillatory activity in the prefrontal cortex
(Siapas et al., 2005; Brockmann et al., 2011), and is implicated
in episodic and working memory, and the top-down control
of cognitive functions (Uhlhaas et al., 2008). PV+ projection
neurons in the basal forebrain can also regulate higher-frequency
gamma-band oscillations (30–80Hz), which are involved in
higher cognitive functions such as feature binding, attention, and
memory (Kim et al., 2015). The PV+ projection neurons in the
medial septum and ventral diagonal band are also important
for regulating hippocampal neurogenesis. For example, partial
septohippocampal GABAergic denervation has been shown to
reduce the survival of newly generated hippocampal neurons
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FIGURE 3 | Nkx2-1 is expressed in a subcortical neuroendocrine network involved in social behavior and reproduction in the rodent brain. The
posterodorsal medial amygdala, ventral lateral septum, and posteromedial bed nucleus of the stria terminalis, provide major inputs to the hypothalamic
neuroendocrine effector system. Neuroendocrine hypothalamic nuclei provide feedback to the posterodorsal medial amygdala, and the ventral lateral septum.
by approximately 40% in rats (Van der Borght et al., 2005).
Collectively, data from human and animal research supports
a link between schizophrenia and decreased hippocampal
neurogenesis (Reif et al., 2006; DeCarolis and Eisch, 2010; Allen
et al., 2015).
Activation of the Nkx2-1 expressing cholinergic projection
neurons may change the direction of information flow within
cortical circuits, and it has been suggested that the cholinergic
projections support a common electrophysiological function in
cortical target areas by increasing the amplitude and signal-
to-noise ratio of sensory responses, while enhancing response
selectivity (Castillo et al., 1999; Eggermann and Feldmeyer,
2009). This function has different effects on psychological
processes depending on the neural network operations within
the various cortical domains (Everitt and Robbins, 1997).
The Nkx2-1 expressing cholinergic projection neurons in the
rodent basal forebrain enhance GABAergic transmission in
cortical interneurons, with a concomitant decrease in the
firing of principal cells, thereby contributing to the promotion
of low-frequency theta oscillations (Griguoli and Cherubini,
2012). In addition, cholinergic neurons recruit noncholinergic
neurons that are required for hippocampal theta synchronization
(Dannenberg et al., 2015).
The notion that basal forebrain cholinergic projection
neurons may be dysfunctional in schizophrenia is supported by
the finding that schizophrenic patients show less stable cortical
signals with a lack of stimulus-related phase-synchronization of
electromagnetic activity after stimulus presentation (Winterer
et al., 2000). Patients tend to increase noise instead of building up
a signal, thus generating a reduced signal-to-noise ratio during
information processing. In support of this, a study of event-
related blood-oxygen-dependent responses showed that noise
variance strongly correlated with psychotic symptoms (Winterer
et al., 2006).
The cholinergic neurons also play a role in spatial learning,
which is impaired in mice after postnatal deletion of Nkx2-1-
expressing cholinergic neurons in the basal forebrain (Magno
et al., 2011). Spatial learning is known to be impaired among
individuals with schizophrenia (Wilkins et al., 2013).
Social Processes and Reproduction; A
Neuroendocrine Network
Social recognition, affiliation, and attachment are all adversely
affected in schizophrenia. Not surprisingly, the typical post
pubertal onset of schizophrenia has stimulated interest in
the potential contribution of neuroendocrine mechanisms and
gonadal hormones (Walker and Bollini, 2002; Markham, 2012;
Trotman et al., 2013).
Nkx2-1 displays a prominent lifelong expression in the
highly interconnected neural neuroendocrine network that links
sensory, hormonal, and homeostatic signals to social recognition
and affiliation, reproduction, and parenting behaviors (Magno
et al., 2009). This network includes subnuclei and cell groups
in the amygdala, the lateral septum, the islands of Calleja, the
hypothalamus, and the pituitary (Figure 3). As this network has
been neatly delineated, it will be discussed in some detail.
Cell groups that express Nkx2-1 are present in all parts
of the amygdala complex during pre- and postnatal mouse
development. In adults, Nkx2-1 expression is restricted to a small
population of subnuclei. Its most pronounced expression is seen
in subnuclei involved in the processing of olfactory and steroid
hormone information into socio-sexual, neuroendocrine, and
reproductive responses; these include the posterodorsal medial
amygdala nucleus, the posteromedial bed nucleus of the stria
terminalis, and the ventral anterior amygdala (Garcia-Lopez
et al., 2008) (Figure 4). These subnuclei represent a pallidal-like
output apparatus with projections to downstream targets in the
neuroendocrine hypothalamus.
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FIGURE 4 | Nkx2-1 expression in mature amygdala nuclei, and the stria
terminalis in the rodent brain is restricted to subnuclei involved in
social, reproductive, and fear-defense responses. (A) Expression occurs
in the posterodorsal and posteroventral medial nuclei, the ventral part of the
anterior nucleus, the medial part of the central nucleus, the medial extended
amygdala, and the posteromedial bed nucleus of the stria terminalis. (B)
Details of the medial amygdala nucleus. Nkx2-1 is expressed by 70% of
neurons in the posterodorsal medial nuclei (social-reproductive) and 30% of
neurons in the posteroventral medial nuclei (fear-defense), suggesting different
roles for NKX2-1 in the two sets of responses.
The lateral septum is a node responsible for integrating
the cognitive and affective information that control behavioral
responses to particular environmental stimuli (D’Anna and
Gammie, 2009; Freiria-Oliveira et al., 2009; Lee and Gammie,
2009). Nkx2-1 is expressed in several proliferating domains in the
rodent lateral septum during early development (Flames et al.,
2007). In adult rodents, conspicuous expression of Nkx2-1 was
detected in a group of large CB+ neurons in the ventral part of
the lateral septum that projects to neuroendocrine hypothalamic
subnuclei (Garcia-Lopez et al., 2008; Xu et al., 2008; Magno et al.,
2009).
The islands of Calleja in the ventral striatum/pallidum
constitute another olfactory and chemosensory neuroendocrine
striato-pallidal system which impacts social affiliation, pair
bonding, and reproduction. In rodents, some neuronal clusters
persistently express Nkx2-1 (Fallon et al., 1983; Magno et al.,
2009; Novejarque et al., 2011).
Neuroendocrine hypothalamic subnuclei involved in mating,
fertility, reproduction, and the integration of reproduction with
other homeostatic and environmental signals include the central
part of the medial preoptic nucleus, the ventrolateral part
of the ventromedial hypothalamic nucleus, the anteroventral
periventricular nucleus, and the ventral premammillary nucleus
(Lee et al., 2001; Magno et al., 2009; Matagne et al., 2012).
In rodents, Nkx2-1 is highly expressed in the neuroendocrine
hypothalamus. Nkx2-1 contributes to the control of sexual
maturation in mice, with expression increasing abruptly at
puberty in order to repress the transcription of genes that
inhibit puberty (e.g., proenkephalin; Lee et al., 2001) and to
activate genes that drive puberty (such as gonadotropin-releasing
hormone) (Matagne et al., 2012). Nkx2-1 also participates in the
maintenance of the female reproductive cycle, which necessitates
changes in gonadotropin-releasing hormone (Ojeda et al., 2000,
2006; Mastronardi et al., 2006; Provenzano et al., 2010).
In the rat anterior pituitary, Nkx2-1 mRNA is expressed in
growth hormone/prolactin-containing neurons, where Nkx2-1
inhibits transcription of the gene encoding growth hormone,
while activating transcription of the gene encoding prolactin.
These observations suggest that Nkx2-1 plays a role in
regulating the trans-differentiation of neurons containing these
two hormones (Lee et al., 2007). In the posterior pituitary
in rodents, Nkx2-1 expression is localized to specialized
astrocytes, called pituicytes, which are involved in regulating the
secretion of oxytocin and vasopressin into general circulation
(Theodosis, 2002; Magno et al., 2009; Rosso and Mienville,
2009).
The neuroendocrine neural network is sexually dimorphic. It
is enriched in gonadal steroid hormone receptors (Coolen and
Wood, 1998; Spiteri et al., 2010; Griffin and Flanagan-Cato, 2011)
as well as the neuropeptides vasopressin and oxytocin, which are
important modulators of network activity (Gabor et al., 2012;
Gur et al., 2014). The functional connectivity of this network
has been characterized in sheep. During parturition, levels of
oxytocin mRNA increase in the islands of Calleja, the medial
amygdala, the posteromedial bed nucleus of the stria terminalis,
the lateral septum, and the neuroendocrine hypothalamic nuclei
(Broad et al., 1999).
Several lines of evidence indicate that the neuroendocrine
network that links sensory, hormonal, and homeostatic signals
to a broad range of social behaviors is adversely affected in
schizophrenia. Developmental changes in both positive and
negative schizophrenic symptoms increase exponentially as the
individual passes through adolescence and approaches early
adulthood. The age at which positive symptoms first appear
differs between males and females, which may be due to later
puberty and associated maturational processes in boys (Galdos
and van Os, 1995). A negative correlation between menarche
age and schizophrenia onset has also been reported by some
investigators (Cohen et al., 1999), although these findings have
yet to be replicated by others (Ruiz et al., 2000; Hochman and
Lewine, 2004). However, higher negative-symptom scores and
greater functional impairment have been associated with subjects
who reported a later age at menarche (Hochman and Lewine,
2004).
Schizophrenia is also associated with gonadal and sexual
dysfunction, as emphasized in a report describing sexual
function in first-episode schizophrenia patients (Malik
et al., 2011). Menstrual irregularities and amenorrhea
Frontiers in Behavioral Neuroscience | www.frontiersin.org 8 March 2016 | Volume 10 | Article 59
Malt et al. NKX2-1 and Schizophrenia
associated with psychosis were described long before the
introduction of neuroleptic drugs (Kohen and Wildgust,
2008). Elevated basal levels of prolactin and growth hormone,
aberrations in neuroendocrine-stimulation tests, and abolished
diurnal hormonal variation also occurs in neuroleptic-naive
schizophrenic patients (Kahn et al., 1992; Warner et al., 1993;
Rao et al., 1994; Muller-Spahn et al., 1998).
Investigations into the circulating levels of vasopressin
and oxytocin in patients with schizophrenia have returned
inconsistent results (Raskind et al., 1987; Legros et al., 1992).
Plasma levels of oxytocin in patients with schizophrenia
appear to be lower than in healthy individuals, particularly
in patients exhibiting hyponatremic polydipsia and emotional
deficit (Goldman et al., 2008). Lower endogenous oxytocin
levels have consistently been associated with impaired social
cognition, especially for lower-level processes such as facial-affect
perception (Strauss et al., 2015).
Parenting behaviors, which are also mediated through the
Nkx2-1-expressing neuroendocrine social-reproductive network
in rodents, have been a major concern for female schizophrenia
patients after giving birth. Mothers with schizophrenia ordinarily
have difficulty with the practical aspects of caregiving and tend
to interact less sensitively with their infants (Abel et al., 2005).
Fathers with schizophrenia also experience difficulty with their
parental role (Jungbauer et al., 2010).
The social-neuroendocrine network is also of interest with
respect to pharmacological interventions in schizophrenia.
Intranasal administration of oxytocin may improve social
cognition and social skills in patients (Gibson et al., 2014;
Mercedes Perez-Rodriguez et al., 2015; Rich and Caldwell, 2015).
The islands of Calleja have received particular attention due
to their dense innervation by dopaminergic projections and
their high expression of dopamine D3 receptors. These receptors
have been suggested to mediate the unique antipsychotic
effects of clozapine and are currently a major target for drug-
discovery programs related to schizophrenia (Guo et al., 1998;
Davoodi et al., 2014). Abnormal hormone responses elicited
by gonadotropin-releasing hormone have been detected in
schizophrenic patients (Brambilla et al., 1976; Ferrier et al., 1983;
Cantalamessa et al., 1985). Beneficial effects on positive and
negative symptoms, as well as the exacerbation of schizoaffective
psychosis, have also been described in case reports following
treatment with gonadotropin-releasing hormone analogs (Soreni
et al., 2004; Abu-Tair et al., 2007).
In summary, multiple lines of evidence indicate a disrupted
social-neuroendocrine network in schizophrenia. Nkx2-1’s
prominent expression in this network indicates that this
transcription factor may be an important modulator of network
activity, and, as a result, could influence the physiological
processes and social behaviors that are disturbed in patients with
schizophrenia.
Fear and Defensive Responses
Individuals who suffer from schizophrenia often exhibit marked
and stable deficits in fear perception and recognition; it has
been suggested that schizophrenic patients suffer from a general
disconnect in the processing of danger signals between the central
and autonomic systems (Williams et al., 2007). Although the
most pronounced expression of Nkx2-1 is seen in the social
neuroendocrine neural network, it is also highly expressed, in
rodents, in the core of a subcortical neural network, which
is involved in fear perception, defense, and escape responses.
This network comprises the posteroventral medial amygdala,
the anteromedial and posteromedial bed nucleus of the stria
terminalis, some neuronal groups in the medial part of the
ventral anterior, the medial central amygdala nucleus, and the
hypothalamic dorsal premammillary nucleus (Choi et al., 2005;
Garcia-Lopez et al., 2008; Magno et al., 2009; Carney et al., 2010)
(Figure 4). Electrical stimulation of the hypothalamic part of
this network elicits somatomotor and autonomic responses that
resemble the behavior of animals facing natural threats. This
fear network has been shown to be critical for the defensive
responses (flight or freezing) elicited in animals in the presence
of a predator (Canteras, 2002).
The investigation of fear-related behavior in patients with
schizophrenia indicates that their fear system is hyper-activated.
In a study of 1030 patients, 27% were found to exhibit “flight”
behavior (Wang et al., 1997). In another study, of auditory
hallucination, patients reported that they experienced these
voices as powerful, dominating, and controlling; these provoked
subordinate defensive responses, especially the fight/flight
response (Gilbert et al., 2001). The initial “flight” behavior of
patients in medical consultations, which is so frequently seen, has
been suggested to be specific for schizophrenia, and is associated
with the symptoms of the illness (Dimic et al., 2010).
In rats, the fear circuitry that we’ve just described mediates
the freezing behavior that dominates fear responses to dominant
males, and the risk assessment behaviors elicited by contextual
fear of social defeat (Faturi et al., 2014). This is highly relevant
for the social defeat hypothesis for schizophrenia, that posits
that social defeat (i.e., the negative experience of being excluded
from the majority group) is the common denominator of five
major schizophrenia risk factors: urban upbringing, migration,
childhood trauma, low intelligence, and drug abuse (Selten and
Cantor-Graae, 2007; Selten et al., 2013).
The Nkx2-1 expressing, fear-defense related network, is
so intimately connected, anatomically and functionally, with
the social-neuroendocrine network, that activation of the fear
network inhibits the social-neuroendocrine network. In a
behavioral context this means that, upon the appearance of
a threatening stimulus, a “gate control” mechanism ensures
the rapid shut-down of the social-neuroendocrine network and
associated behaviors in order to aid survival (Choi et al., 2005;
Carney et al., 2010). Accordingly, a permanent hyper activation
of the fear-defense network may have substantial implications for
pro-social behaviors.
Regulatory and Homeostatic Systems
Circadian Rhythms, Sleep and Other Effects of Light
The influence of light on physiology and behavior (its so
called masking behavior), extends to melatonin synthesis, daily
activity, circadian rhythm, and sleep. Studies indicate that
photic neurotransmission and photosensitive gene regulation are
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significant in schizophrenia and that the deregulation of masking
behaviors are a common finding (Miller, 2013).
Melanopsin containing, adenylate cyclase-activating
polypeptide producing intrinsically photosensitive retinal
ganglion cells (ipRGCs), play a central role in transmitting
photic information to non-visual target areas in the brain
(Schmidt et al., 2011). Nkx2-1 is highly expressed in ipRGCs,
where it is thought to regulate the transcription of adenylate
cyclase-activating polypeptide, which is essential for the
maintenance of photic sensitivity (Son et al., 2007; Kawaguchi
et al., 2010).
The ipRGCs transmit daytime light information to the
hypothalamic suprachiasmatic nucleus (SCN), and in doing so,
contribute to circadian rhythms (Hattar et al., 2006). They also
innervate several hypothalamic and pretectal areas involved in
the control of masking behavior, regulation of the sleep-wake
state, control of the pupillary light reflex, regulation of pineal
melatonin levels, circadian oscillation of core body temperature,
and neuroendocrine processes related to reproductive function
(Hannibal, 2006; Hattar et al., 2006; Bailes and Lucas, 2010).
Nkx2-1 is also expressed in many of the down-stream
targets that receive projections from ipRGCs, including the
hypothalamic nuclei involved in the regulation of circadian
rhythms: the dorsomedial hypothalamic nucleus and the SCN
(Nakamura et al., 2001; Son et al., 2009). The dorsomedial
hypothalamic nucleus is the key output nucleus of the brain’s
circadian system, as it is involved in circadian activation of a wide
range of behavioral and endocrine functions (Chou et al., 2003).
The SCN contains the circadian master clock. In the murine
SCN, Nkx2-1 is expressed in neurons that express the protein,
period-2 (Kim et al., 2002). In the rat SCN, period-1 and -2,
additively stimulate the transcription of angiotensinogen, which
integrates changes in the light-cycle with circadian variation
in blood pressure and heart rate (Son et al., 2009). Essential
elements of the master clock, such as the circadian locomotor
output cycles kaput protein, and the aryl hydrocarbon receptor
nuclear translocator-like protein, suppress Nkx2-1 expression
(Kim et al., 2002). There is also evidence that Nkx2-1 is involved
in generating a daily rhythm via its regulation of hypothalamic
pituitary adenylate cyclase-activating polypeptide expression in
rats (Kim et al., 2002). This process is required for the normal
integration of the phase-advancing light signal (i.e., light induced
changes to the circadian rhythm) by the SCN, and may be
involved in synaptic plasticity in the hypothalamus (Gasperini
et al., 2012).
The wide range of masking behaviors that are affected
in schizophrenia indicate that the Nkx2-1 expressing neural
network may be dysfunctional. Disturbances in circadian rhythm
and the regulation of the sleep-wake state are generally observed
and often appear as prodromal signs prior to the first and
subsequently recurring psychotic episodes (Nishino et al., 2002;
Karatsoreos, 2014; Manoach et al., 2014). Alteration in the
synthesis and circadian rhythm of melatonin has also been
reported (Monteleone et al., 1992, 1997; Rao et al., 1994).
Compared to controls, patients with schizophrenia generally
exhibit a deregulated body temperature, including a different
baseline temperature, an abnormal daily temperature range, and
an impaired ability to compensate for temperature stress (Chong
and Castle, 2004; Shiloh et al., 2009). Significant alterations in
pupillomotor control, with abnormal latencies and decreased
light reaction, have also been reported (Bar et al., 2008). For
example, a 10-fold higher stimulus intensity was required to
induce a pupillary light reaction in patients with schizophrenia
compared to controls (Rubin and Barry, 1976).
Although the major function of ipRGCs is to support
non-image forming behaviors, their innervation pattern to
the superior colliculus, the intergeniculate leaflet, and lateral
geniculate nucleus, suggests that they relay inputs from the visual
system to centers and circuits involved in the orientation of
the head and eyes to sensory stimuli, image-forming vision,
luminance, and spatial information (Ecker et al., 2010; Schmidt
et al., 2011). This opens the possibility that abnormalities seen
in early visual processing in schizophrenia might be influenced
by Nkx2-1 expressing ipRGCs (Koychev et al., 2011; Khosravani
and Goodarzi, 2013; Nunez et al., 2014; Lee et al., 2016).
Regulation of Food Intake
Long before the discovery of the neuroleptics, the altered
consumption of food was noted in patients with schizophrenia,
with substantial variations in food intake and large weight
fluctuations over comparatively short periods of time (Kraepelin,
1919). Modern studies have also revealed that schizophrenia
is often associated with eating disorders (Kouidrat et al.,
2014). Anorexia nervosa affects between 1 and 4% of patients
with schizophrenia. In addition, binge eating- and night
eating disorders have an average prevalence of 5–20% in the
schizophrenic population, which is approximately five fold that
of the general population (Kouidrat et al., 2014). Themechanisms
behind these altered eating behaviors are poorly understood.
One of the hypothalamic nuclei with a high continuous
expression of Nkx2-1 is the arcuate nucleus, the master
hypothalamic center for feeding control (Kim et al., 2002,
2006, 2011; Yee et al., 2009; Kaji and Nonogaki, 2013). In
rodents, Nkx2-1 is selectively expressed in the two main
centrally projecting cell populations involved in the regulation of
feeding behavior; neurons containing the agouti-related protein
and neuropeptide Y, and neurons containing peptide products
of pro-opiomelanocortin and the cocaine and amphetamine-
regulating transcript (Kim et al., 2006; Yee et al., 2009; Kaji
and Nonogaki, 2013). Nkx2-1 stimulates transcription of agouti-
related protein and inhibits transcription of the gene encoding
pro-opiomelanocortin; up-regulation of Nkx2-1 has also been
shown to increase appetite and eating (Kim et al., 2011).
Neuroleptic drugs are associated with varying degrees of
weight gain, and direct or indirect effects on the hypothalamic
neuronal circuits that control food intake and satiety represent
plausible causal mechanisms for these side-effects (Kouidrat
et al., 2014). Sub-chronic exposure to olanzapine, which leads
to hyperphagia and weight gain in rats, is associated with
the up-regulation of agouti-related protein/neuropeptide Y,
and down-regulation of the pro-opiomelanocortin/cocaine and
amphetamine-regulating transcript in the arcuate nucleus (Ferno
et al., 2011; Weston-Green et al., 2012). Given that Nkx2-1
ordinarily regulates the balance between these two proteins,
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the possibility exists that olanzapine’s side effects related to
hyperphagia and weight gain may be mediated by up-regulated
Nkx2-1. As yet, this possibility has not been explored.
Osmoregulation, Water Balance, and Sympathetic
Outflow
Patients with schizophrenia often display alterations both in
central and peripheral water balance. Multiple studies of
the brains of patients with schizophrenia have uncovered
abnormalities in their volume of cerebrospinal fluid. In a meta-
analysis, ventricular cerebrospinal fluid volume was 20–30%
higher in schizophrenic patients (Wright et al., 2000). A smaller
increase of 7% was reported in a large Finnish cohort study which
took into account both the ventricular and external volumes of
cerebrospinal fluid (Tanskanen et al., 2009). In rats, Nkx2-1 has
a regulatory role in the formation of cerebrospinal fluid. Nkx2-
1 is expressed in the apical membrane of the ventricular choroid
plexus, where it regulates expression of the water-channel protein
aquaporin-1(Kim et al., 2007). This protein plays an essential
role in the homeostasis of intracellular and extracellular water in
the brain, and blockade of Nkx2-1 decreases cerebrospinal fluid
formation by approximately 20% (Kim et al., 2007).
Deregulation of body-fluid homeostasis is also a well-known
phenomenon in patients with schizophrenia. Primary polydipsia
is the most common physiologic abnormality andmay be present
in more than 20% of chronic inpatients (de Leon et al., 1994).
Increased sensitivity to osmotic stress and water intoxication
due to polydipsia have often been described (Hundt et al., 2001;
Bralet et al., 2007; Goldman et al., 2007; Satoh et al., 2007; Siegel,
2008; Goldman, 2009). In rats, Nkx2-1 influences water intake
(Son et al., 2003). Nkx2-1 is expressed in the circumventricular
organs; the organum vasculosum of the lamina terminalis,
and the subfornical organ (Kim et al., 2008). Nkx2-1 activates
transcription of the gene encoding angiotensinogen after water
deprivation or dehydration, which influences drinking behavior.
Patients with schizophrenia regularly exhibit altered
regulation of sympathetic outflow (Bar et al., 2007; Chang
et al., 2009). Nkx2-1 is indirectly involved in autonomic
regulation, as a major central target for angiotensinogen from
the subfornical organ is the hypothalamic paraventricular
nucleus, where it is converted to angiotensin II. Angiotensin
II in the paraventricular nucleus increases the activity of the
brain renin-angiotensin system and contributes to autonomic
output and sympathoexcitation (Ferguson and Bains, 1997;
Kang et al., 2009). Angiotensinogen from the subfornical organ
also influences neuroendocrine secretion of adrenocorticotropic
hormone, oxytocin, and vasopressin from the pituitary gland
(Bartanusz and Jezova, 1994; Macova et al., 2009).
Integration of Trophic and Metabolic Processes and
the Regulation of Brain-Body Homeostasis
In mice, Nkx2-1 demonstrates a high, lifelong expression in
tanycytes, although, to our knowledge, the role of Nkx2-1 in
these cells has not yet been explored. Tanycytes are specialized
astrocytes located in the periventricular area that bridges the
lumen of the third ventricle with the blood vessels of the medial
basal hypothalamus (Lee et al., 2001). Their strategic proximity
to, and relationship with, fenestrated capillaries, the blood brain
barrier, axonal nerve terminals, and hypothalamic nuclei that
regulate appetite/energy expenditure, places them in a privileged
position with which to integrate multiple inputs and regulate
homeostasis (Goodman and Hajihosseini, 2015). Although much
is still unknown about the specific roles of tanycytes, they
are known to regulate the release of gonadotropin-releasing
hormone and to participate in the regulation of the hypothalamo-
pituitary-gonadal axis (Fekete and Lechan, 2014). They may
also act as glucosensors and participate in the control of
insulin secretion (Frayling et al., 2011). Tanycytes function as
gatekeepers of thyroid-hormone level in the hypothalamus and
regulate the hypothalamic-pituitary-thyroid axis during fasting
and infection (Lechan and Fekete, 2007; Herwig et al., 2008;
Fonseca et al., 2013; Fekete and Lechan, 2014). Currently, there
are no reports about tanycytes in schizophrenia. However, their
role in body-brain communication and homeostatic regulation
should make them of interest in schizophrenia research.
THYROID HORMONE HOMEOSTASIS
The available evidence supports thyroid hormone deregulation
as a common feature in schizophrenia (Santos et al., 2012).
In humans, NKX2-1 is necessary for organogenesis and the
development of the thyroid gland (Kimura, 1996; Suzuki et al.,
1998a; Damante et al., 2001). NKX2-1makesmajor contributions
to the maintenance of normal thyroid-hormone homeostasis by
regulating expression of the thyrotropin-stimulating hormone
receptor, thyroglobulin, thyroid peroxidase, the sodium/iodide
symporter, and type II iodothyronine deiodinase (Berg et al.,
1996; Endo et al., 1997; Suzuki et al., 1999; Damante et al., 2001;
Gereben et al., 2001; Moeller et al., 2003).
Thyroid Hormones and the Brain
Thyroid hormones exert profound neurodevelopmental
effects; even modest disruption during critical periods of fetal
development can influence mature brain function (Zoeller
and Rovet, 2004; Oerbeck et al., 2007; Flamant et al., 2015).
Triiodothyronine depletion results in the delayed expression of
oligodendrocyte-specific markers, fewer oligodendrocyte cell
bodies in the main white-matter tracts, delayed expression of
genes encoding structural myelin proteins, fewer myelinated
axons, and a lower myelin content (Valcana et al., 1975;
Ibarrola and Rodriguez-Pena, 1997; Mohacsik et al., 2011). The
maturation of GABAergic PV+ neurons depends heavily on
thyroid hormones; deficiency during the early postnatal period
in rats (corresponding to 5–6 months of gestation in humans)
reduced PV immunoreactivity in GABAergic interneurons in the
adult neocortex and hippocampus, leading to a compromised
inhibitory function (Gilbert et al., 2007). Adult neural stem
cell cycling and the maintenance of hippocampal pyramidal
neuron populations depend on the modulation of specific
cell-cycle regulators by thyroid hormones (Lemkine et al., 2005;
Alva-Sanchez et al., 2009). Thyroid hormones also affect synaptic
proteins (Yang et al., 2012) and glucose metabolism (Bauer et al.,
2009), and protect the brain from oxidative stress by maintaining
glutathione homeostasis (Dasgupta et al., 2007).
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Brains from patients with schizophrenia display alterations
that are compatible with the pre- and postnatal depletion of
thyroid hormones. These alterations include oligodendrocyte
abnormalities, defects in white matter tracts, and the dysfunction
of PV+ GABAergic interneurons (Behrens and Sejnowski,
2009; Melicher et al., 2015). There are also findings suggestive
of reduced neural stem-cell proliferation (Reif et al., 2006),
presynaptic dysfunction (Castillo et al., 2010), and deficits in
glucose metabolism and glutathione homeostasis (Katz et al.,
1996; Gysin et al., 2007; Do et al., 2009; Yao and Keshavan, 2011).
Thyroid Autoimmune Disease
Data from Danish registries show that the incidence of Graves’
disease and autoimmune thyroiditis is increased in patients
with schizophrenia and their parents, and that a history of
any autoimmune disease is associated with a 45% increase in
the risk of schizophrenia (Eaton et al., 2006; Benros et al.,
2014). Autoimmune thyroid disease can be associated with
other autoimmune endocrine failures or non-endocrine diseases
(vitiligo, pernicious anemia, myasthenia gravis, autoimmune
gastritis, celiac disease, hepatitis; Wemeau et al., 2013). Several
of these disorders have also been associated with schizophrenia
(Zoabi et al., 2012; Benros et al., 2014).
Autoimmune thyroid disease is provoked by a loss of self-
tolerance to the autoantigens thyroid peroxidase thyroglobulin,
and thyroid stimulating hormone receptor, which leads to a
destructive immune infiltration of the gland. NKX2-1 promotes
the expression of these thyroid autoantigens, and the up-
regulation of NKX2-1 results in a concomitant increase
in human leukocyte antigen (or major histocompatibility
complex (MHC) class I expression, together with the thyroid
autoantigens. This may constitute the pathologic state that
leads to thyroid autoimmune disease (Huang et al., 2011).
Bacterial lipopolysaccharide, which has been proposed to be
another etiopathogenic agent in autoimmune disease, also up-
regulates the expression of thyroid antigens by increasing Nkx2-
1 expression in rats (Velez et al., 2006). It has recently been
shown that the strong genetic association between variation in
the MHC locus and schizophrenia arises, in part, from the many
structurally diverse alleles of the complement component 4 (C4)
gene (Sekar et al., 2016). Autoimmune thyroid disease can also
be mediated by direct binding of complement C4 to thyroid
peroxidase (Blanchin et al., 2003). Whether NKX2-1 is directly
involved in this process has yet to be explored.
CALCIUM HOMEOSTASIS AND BONE
CELL METABOLISM
Research has demonstrated that impaired calcium homeostasis
and signaling is common to many schizophrenia-related
processes, including dysregulated dopamine and glutamate
neurotransmission (Bergson et al., 2003; Martins-de-Souza
et al., 2009a,b; Bojarski et al., 2010). Platelets from drug-
free schizophrenia patients harbor significantly higher levels of
cytosolic calcium than healthy controls (Ripova et al., 1997);
data from a recent GWAS also supports the involvement of
calcium-signaling in schizophrenia (Hertzberg et al., 2015).
Chief cells in the parathyroid gland coordinate with thyroid
neuroendocrine C cells to maintain calcium and phosphorus
levels in the blood, as well as bone-cell metabolism throughout
the body. C cells secrete calcitonin, and in rats, Nkx2-1 activates
transcription of calcitonin (Suzuki et al., 1998b, 2007). Calcitonin
decreases serum calcium levels, increases calcium levels in
cerebrospinal fluid, increases serum concentrations of 1,25-
dihydroxyvitamin D, inhibits bone resorption, and regulates
phosphorus metabolism (Carmen and Wyatt, 1977; Felsenfeld
and Levine, 2015). In patients with schizophrenia, injections
with synthetic salmon calcitonin have been shown to decrease
agitation, and improve malignant catatonia (Carmen and Wyatt,
1977; Carman and Wyatt, 1979a, Carman and Wyatt, 1979b).
Nkx2-1 is also expressed in rat chief parathyroid cells (Suzuki
et al., 1998a), with binding sites for Nkx2-1 present within genes
encoding the calcium sensor receptor and calmodulin. Nkx2-
1 may therefore act as an important calcium-sensing factor
that responds to altered intracellular calcium levels in order
to regulate the gene expression required to maintain calcium
homeostasis (Suzuki et al., 1998b). Animals with abnormal
calcium homeostasis, after removal of the parathyroid gland,
exhibit changes in basal dopamine and noradrenaline levels in
limbic structures, abnormalities in conditioned reflex activity,
and the acquisition of adaptive behavioral strategies (Sashkov
et al., 2007).
Regulation of bone formation and turnover is a main function
of chief and parafollicular cells. Bonemetabolism has been shown
to be disturbed in patients with schizophrenia and decreased
bone mineral density and osteoporosis are common in these
patients. Schizophrenia has been found to be an independent
determinant of a poor skeletal status in women after controlling
for common risk factors such as osteoporosis, vitamin D status,
and medication (Partti et al., 2010). From a young age, both men
and women with schizophrenia present a lower bone mass than
the general population (Renn et al., 2009).
THE RESPIRATORY SYSTEM
Patients with schizophrenia have significantly lower lung-
function values than control subjects after adjustment for
smoking and other potential confounders (Partti et al., 2015).
They experience a higher incidence of lung disease such as
asthma, chronic obstructive pulmonary disease, and pneumonia
(Carney et al., 2006; Filik et al., 2006; Copeland et al., 2007; Chen
et al., 2009). Schizophrenic patients aged 10–39 years and 40–49
years are eight times and five times more likely, respectively, to
die from respiratory causes (Partti et al., 2015).
NKX2-1 is highly expressed in the lungs, where it regulates
the expression of several genes critical to lung development
and mature function (Bohinski et al., 1994; Li et al., 2000,
2002; Naltner et al., 2000; Yuan et al., 2000; Berhane and
Boggaram, 2001; Zhou et al., 2001; Reynolds et al., 2003; Zhu
et al., 2004; Reynolds and Hoidal, 2005; Sparkman et al., 2006;
Besnard et al., 2007; Spiteri et al., 2007; Minoo et al., 2008;
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Boggaram, 2009; Kolla et al., 2009; Tagne et al., 2012; Li C.
et al., 2013; Zscheppang et al., 2013). In the adult mouse lung,
Nkx2-1 is expressed predominantly in two special cell types,
the alveolar type II epithelial cell, and Clara cells (Boggaram,
2009).
Alveolar type II cells are responsible for the production of
surfactant; in rodents, rabbits and humans, Nkx2-1/NKX2-1
positively regulates the expression of surfactant proteins A, B,
and C (Margana et al., 2000; Yi et al., 2002; Alcorn et al.,
2004; Liu et al., 2008; Cao et al., 2010). Surfactant protein A
interacts with a wide range of pathogens to suppress microbial
growth, damage bacterial membranes, modulate macrophage
phagocytosis, clear lipopolysaccharide, and regulate complement
activation (Kishore et al., 2006). Surfactant proteins B and C are
critical in lowering the surface tension at the air/water interface,
and for airway host defense (Chroneos et al., 2010). Abnormal
expression and activity of surfactant proteins have been suggested
to underlie the pathogenesis of a variety of lung inflammatory
diseases, including asthma and chronic obstructive pulmonary
disease (Kishore et al., 2006; Chroneos et al., 2010). Consistent
with this hypothesis, patients with heterozygous loss-of-function
mutations in NKX2-1 are predisposed to neonatal respiratory
distress and pulmonary infections due to reduced expression of
surfactant proteins (Krude et al., 2002).
Clara cells located in the bronchioles secrete surfactant
protein B and Clara cell secretory protein (CCSP), both of
which are transcriptional targets of NKX2-1 (Ray et al., 1996;
Cassel et al., 2000; Margana et al., 2000). CCSP is a natural
immuno-suppressant and anti-inflammatory secretory protein
that exhibits several immunomodulatory features, including
helper T-cell regulation (Dierynck et al., 1996; Hung et al.,
2004; Johansson et al., 2007). Reduced plasma CCSP levels have
been reported in patients with schizophrenia, and it has been
suggested that inflammatory responses in schizophrenia may be
causally related to lower serumCCSP levels, whichmay represent
a biomarker for the disorder (Maes et al., 1996a,b; Lin et al.,
1998).
THE ENTERIC NERVOUS SYSTEM
Gastric dysmotility and enteric nervous-system dysfunction are
common in schizophrenic patients (Peupelmann et al., 2009;
Berger et al., 2010). In humans, NKX2-1 is expressed in
mature enteric ganglia, where it regulates expression of the ret
proto-oncogene by interacting with the transcription factors
paired-like homeobox 2B, and sex-determining region Y-box 10
(Leon et al., 2009). Both of these are genes have been associated
with susceptibility to schizophrenia (Ide et al., 2005; Maeno et al.,
2007b; Glessner et al., 2010).
THE SKIN
Patients with schizophrenia exhibit skin abnormalities such
as reduced wound healing and an attenuated response to
inflammatory stimuli in the niacin skin-flushing test (Kamolz
et al., 2003; Smesny et al., 2007). In rats, Nkx2-1 is expressed
in keratinocytes and dermal fibroblasts (Suzuki et al., 1998a).
While targets for Nkx2-1 in the skin have yet to be explored,
genes related to thyroid hormones, inflammation, and calcium
homeostasis, that are regulated by Nkx2-1 in other tissues,
are also expressed in keratinocytes and dermal fibroblasts
(Cianfarani et al., 2010; Yun et al., 2011). Skin keratinocytes and
fibroblasts are also generally considered to be a useful model
system for studying vulnerability factors and the pathophysiology
of schizophrenia (Ramchand et al., 1995; Catts et al., 2006; Olsson
et al., 2006; Gysin et al., 2009; Wang et al., 2010).
DISCUSSION
NKX2-1 and Candidate Schizophrenia
Genes
A review of the publically available online database for
genes associated with Schizophrenia (SchizophreniaGene) in
December 2015, revealed in excess of 1000 possible candidate
genes; this database was, until Dec. 2011, regularly updated (Allen
et al., 2008). Some of these candidates were identified during the
pre-GWAS period, with others based on GWAS studies. NKX2-1
is known to interact with a number of these genes (Thome et al.,
1996; Perrone et al., 1999; Stober et al., 1999; Marin et al., 2000;
Naltner et al., 2000; Ojeda et al., 2000; Stoykova et al., 2000; Kim
et al., 2002; Leonard et al., 2002; Yi et al., 2002; Chojnacki and
Weiss, 2004; Cui et al., 2005; Ide et al., 2005; Reynolds andHoidal,
2005; Aghajani et al., 2006; Sanjuan et al., 2006; Takahashi et al.,
2006; Benzel et al., 2007; Hashimoto et al., 2007; Son et al., 2007;
Takao et al., 2007; Kahler et al., 2008; Zhou et al., 2008; Leon et al.,
2009; Carney et al., 2010; Waddington et al., 2010; Goulburn
et al., 2011; Zhang et al., 2011; Crisafulli et al., 2012; Matagne
et al., 2012; Quednow et al., 2012; Li T. et al., 2013; Trotman et al.,
2013; Zscheppang et al., 2013; Luo et al., 2014) (Table 1).
In a recent publication, Farrell et al. (2015) presented genomic
evidence for 25 candidate schizophrenia genes identified during
the pre-GWAS period, including Disrupted in schizophrenia 1,
Neuregulin 1, Nicotinic cholinergic receptor α7, and Receptor-
erb-b4 avian erythroblastic leukemia viral oncogene homolog.
Several of these genes, and their gene products, influence or
are influenced by, Nkx2-1. Disrupted in schizophrenia 1 is
necessary for the migration of Nkx2-1-derived interneurons to
the cortex (Steinecke et al., 2014), and for mature function of the
PV+ subgroup (Sauer et al., 2015). Disrupted in schizophrenia
1 is also involved in adult neurogenesis (Jun et al., 2012), a
process in which Nkx2-1-expressing GABAergic PV+ projection
neurons in the medial septum/ventral diagonal band play a key
role (Van der Borght et al., 2005). Neuregulin 1, brain-derived
neurotrophic factor, and dystrobrevin binding protein 1, are
also of critical importance for the maturation and inhibitory
function of Nkx2-1-derived PV+ neurons (Hashimoto et al.,
2005; Grabert andWahle, 2008; Fazzari et al., 2010; Carlson et al.,
2011; Yin et al., 2013). Neuregulin 1 and nicotinic cholinergic
receptor α7 are involved in the modulation of Nkx2-1-dependent
hippocampal gamma oscillations (Fisahn et al., 2009; Lu and
Henderson, 2010), as well as regulation of plasticity of the
airway epithelium (Maouche et al., 2009). In the lungs of
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mice, signaling via neuregulin 1, and its receptor-erb-b4 avian
erythroblastic leukemia viral oncogene homolog, activates Nkx2-
1 expression (Zscheppang et al., 2013), while Nkx2-1 activates
nicotinic cholinergic receptor α7 transcription (Reynolds and
Hoidal, 2005).
Multiple GWASs have identified a relatively large number of
single-nucleotide polymorphisms, each contributing a small risk
for the disorder. A meta-analysis of 18 GWASs for schizophrenia
supported involvement of the MHC region, TCF4, POM121L2,
NOTCH4, AS3MT, CNNM2, and NT5C2 (Aberg et al., 2013).
Transcription factor 4 (TCF4) is implicated in Wnt signaling,
which is critical for the maintenance the proliferation of Nkx2-1-
derived GABAergic interneurons in themouse forebrain (Gulacsi
and Anderson, 2008) and for lung development (Tebar et al.,
2001). Signaling through the Notch receptor may be a common
regulator of neuronal differentiation within the developing
forebrain (Faux et al., 2001). TheNotch receptor ligandNOTCH4
is involved in lung function and remodeling as well as in
protection against innate immune inflammation in the lung,
where it acts on tumor necrosis factor, an upstream suppressor
of NKX2-1 transcription (Boggaram, 2009; Das et al., 2011; Li C.
et al., 2013). NKX2-1 in the human thyroid gland is involved in
the regulation of MHC class I genes (Huang et al., 2011).
Although Nkx2-1 has been shown to interact with a number
of susceptibility genes for schizophrenia, most of these studies
were performed in rodents and species-related differences may
occur. Many of these gene-gene interactions are also described in
tissues other than the brain. However, although transcriptional
targets are often tissue-specific, a significant overlap exists
between transcriptional targets in different tissues. For example,
Spiteri et al. (2007) reported overlaps of 47% and 37% for
genes identified as forkhead box P2 (FOXP2) targets in human
lung and basal ganglia, and in the lung and inferior frontal
cortex, respectively. Interestingly, FOXP2, a candidate gene for
schizophrenia, interacts with NKX2-1 in the human lung, and is
co-expressed with Nkx2-1 in the posterodorsal medial amygdala
nucleus in mice (Carney et al., 2010).
NKX2-1 and the Two Hit Hypothesis
The possible involvement of NKX2-1 in the pathogenesis
and pathophysiology of schizophrenia is fully compatible
with the two-hit hypothesis, underscoring the importance
of environmental factors in this disease (Bayer et al., 1999;
Feigenson et al., 2014). Research using transgenic mice has
determined that early prenatal stress results in significant
fluctuations in the expression of Nkx2-1 and its downstream
targets that affect the distribution of MGE-derived interneurons
in the cortex (Stevens et al., 2013). Immune activation in the fetus
as a result of inflammatory stimuli emanating from the mother is
proposed to represent an important environmental susceptibility
factor for schizophrenia (Brown, 2011; Wischhof et al., 2015).
Nkx2-1-expressing periventricular tanycytes and other cortical
astrocytes in rodents respond to the inflammatory stimulus
provided by lipopolysaccharide. The effects of lipopolysaccharide
are at least partly mediated through regulation of the availability
of triiodothyronine in the brain parenchyma, followed by
changes in triiodothyronine-mediated gene expression involved
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in neurodevelopment and oxidative stress (Klecha et al., 2006).
Prenatal administration of lipopolysaccharide is known to induce
sex-dependent changes in glutamic acid decarboxylase and PV in
the adult rat brain (Basta-Kaim et al., 2015). The effect of gene-
environment interactions have been demonstrated in transgenic
mice expressing a dominant-negative schizophrenia 1 gene;
these mice display histologic and behavioral endophenotypes
that are relevant to schizophrenia. When exposed to an
immune challenge corresponding to viral infection during
the neonatal period, the transgenic mice exhibited impaired
Nkx2-1-associated behaviors, such as fear memory, social
recognition, and social interaction (Ibi et al., 2010). Additive
effects of the disrupted in schizophrenia 1 genotype and
immune challenge were reflected in a marked decrease in
the number of PV+ interneurons in the medial prefrontal
cortex.
Are Dysregulated NKX2-1 Associated
Processes Specific to Schizophrenia?
A central question is whether the disruption of NKX2-
1associated networks and processes should be considered
to be specific to the diagnostic category schizophrenia, or
instead could be of broader relevance to neurodevelopmental
disorders. For example, many genes identified as susceptibility
genes for schizophrenia are also associated with other mental
disorders (e.g., autism spectrum disorders and bipolar disorder).
Overlapping symptoms are also commonly found. Psychotic
symptoms can arise in bipolar disorder, and persistent social
dysfunction is a prominent feature of autism. NKX2-1 expression
patterns have not been explored either in schizophrenia or in
any other neurodevelopmental or psychiatric disorder. However,
patients with schizophrenia certainly have brain dysfunctions
that involve the progeny of NKX2-1 expressing progenitor
cells. Susceptibility to the somatic symptoms related to the
dysfunction of physiological processes regulated by NKX2-
1 are also well documented. To date, we are not aware of
a similar cluster of mental and somatic dysfunction in any
other mental illness, other than schizophrenia. Therefore, we
would propose that aberrant NKX2-1 function could result in
a wide-ranging, multi-organ disorder that is the hallmark of
classic untreated “Kraepelinian” schizophrenia. However, until
results of research into the role of NKX2-1 in schizophrenia,
including comparisons with other highly heritable disorders
are published, our proposal must be regarded as an educated
hypothesis.
IMPLICATIONS FOR RESEARCH
In the past, most schizophrenia research has focused on the brain
or blood. NKX2-1 is not known to be expressed in blood cells,
and analyses performed on blood samples may not be feasible.
However, several alternative ways of studying the role of NKX2-
1 are available. Studies of genetically-engineered, experimental
animals, with variable age- and tissue-specific expression of
Nkx2-1, or its downstream targets, may shed light on relevant
behavioral phenotypes (Fragkouli et al., 2005; Magno et al.,
2011). Studies of the interactions between identified susceptibility
genes and Nkx2-1 may also increase our knowledge about
the mechanisms that underlie altered neurotransmission and
other physiologic processes. Genes that interact with NKX2-
1 also represent a new, and as yet unidentified cohort of
susceptibility genes. A recent interesting GWAS identified
42 sets of single-nucleotide polymorphisms associated with a
70% or greater risk of schizophrenia (Arnedo et al., 2015).
Molecular pathway analyses then indicated that processes
related to neurodevelopment, immunity, neurotransmission,
gene expression, and oxidative stress were all involved in the
pathogenesis of schizophrenia; these are all strikingly similar to
those processes involving NKX2-1. Follow-up work to assess if
those single-nucleotide polymorphisms are related to NKX2-1 is
now needed.
Post-mortem studies in patients with schizophrenia can be
performed to study cell populations developed from NKX2-1-
expressing progenitors. Analyses of the activities of NKX2-1-
related gene pathways in skin biopsies or other tissues can be
correlated with the symptoms and various manifestations of
schizophrenia. Human pluripotent stem cells are a powerful tool
with which to model brain development and disease, and it is
feasible to derive cortical interneurons that express NKX2-1 in
order to investigate their function under diverse experimental
conditions (Maroof et al., 2013). The generation of induced
pluripotent stem cells (iPSCs) from patients with schizophrenia
would also enable in vitro electrophysiological studies of synaptic
function to be conducted for iPSC-derived neurons (Bellin
et al., 2012; Brennand et al., 2012). Such electrophysiological
methods will enable us to study how NKX2-1 impacts synaptic
function in humans, both at the single-neuron level (in vitro),
and non-invasively, in vivo (in the brain). These techniques may
be complemented by novel computational, in silico modeling
of synaptic function. This unique approach has the potential
to provide new, groundbreaking knowledge about disease
mechanisms that could, potentially, inform clinical practice, and
enable the personalized medicine that could improve outcomes
in schizophrenia.
By linking NKX2-1 findings to electrophysiology, such
studies may contribute to an improved understanding of
brain oscillations in schizophrenia. Clinical studies focusing on
the relationships among photic transmission, neuroendocrine
anomalies, and social and emotional deficits and their association
with NKX2-1, should also be performed. The hallmark mental
symptoms of schizophrenia can be further investigated in the
context of immune, thyroid, parathyroid, lung, skin, and gut
pathology. New imaging techniques allow us to explore the
impact of thyroid hormones on brain function and metabolism
(Bauer et al., 2009; Pilhatsch et al., 2011), as well as visualization
of distinct neural circuits (Granziera et al., 2011). New imaging
techniques currently under development will also allow us to
study small structures, deep in the human brain, such as the septal
and amygdala subnuclei, and the hypothalamus (Prestia et al.,
2015).
Although speculative, a possible implication of our emphasis
on the role of the NKX2-1 transcription factor, not only for brain
development, but also in relation to other physiologic defects
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with embryonic origins (e.g., gut, respiratory system), is that
new therapies for diseases associated with those physiological
defects may also be of value to patients with schizophrenia. Our
hypothesis would be markedly strengthened by studies of how
new drug treatments interact with NKX2-1.
CONCLUSION
NKX2-1 may be involved in core, dose-sensitive, molecular
pathways that are deregulated in schizophrenia. This
deregulation may result from the mutation of genes that directly
or indirectly interact with NKX2-1, and/or from environmental
factors that influence epigenetic gene regulation. Deregulated
pathways may involve both under- and over-expression, which
might activate non-physiologic targets, or repress true targets.
Cell type- and tissue-specific factors, together with the timing
and magnitude of dysfunction, could also contribute to the
phenotypic variability of schizophrenia. NKX2-1 conducts key
functions at the interface of the brain, the neuroendocrine
system, and the immune system, and may be an important
mediator of aberrant cross-communication among these systems
in schizophrenia. Knowledge of the processes that involve
NKX2-1 may be of value in devising future treatment strategies
for schizophrenia, including pharmacologic approaches,
deep brain stimulation, and, potentially, stem cell-based
treatments.
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